Status:
RECRUITING
Exercise Program for Arteriovenous Fistula Maturation
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Arteriovenous Fistula
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Arteriovenous fistula (AVF) is the recommended vascular access for chronic hemodialysis, as it is associated with less mortality and better patency than arteriovenous graft (AVG) or central venous cat...
Eligibility Criteria
Inclusion
- Patients older than 18 years
- with chronic kidney disease (Estimated Glomerular Filtration Rate (eGFR) \<30 milliLiter/minute (mL/min))
- with follow-up at the University Hospital of Lyon Sud
- who choose hemodialysis as renal replacement therapy
Exclusion
- contraindication for arteriovenous fistula (AVF) surgery
- refusing AVF creation
- prior vascular access
- antecedent of IV substance abuse
- active cancer
- inability to perform handgrip exercise
- physical or mental disability limiting follow-up possibility
- inclusion in an other interventional study
- no social welfare
Key Trial Info
Start Date :
October 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 4 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04034433
Start Date
October 4 2019
End Date
November 4 2026
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de néphrologie, dialyse et nutrition rénale - Centre Hospitalier Lyon Sud
Pierre-Bénite, France, 69310